Early-life transmission of aromatic lactate-producing bifidobacteria, facilitated by vaginal delivery, older siblings, and exclusive breastfeeding, increases gut aromatic lactate levels and is inversely associated with food allergen-specific IgE development and atopic dermatitis, with 4-hydroxy-phenyllactate mediating this effect by inhibiting IgE but not IgG production.
Key Findings
Results
Early-life colonization by aromatic lactate-producing bifidobacteria was inversely associated with food allergen-specific IgE development up to 5 years of age.
147 children were followed from birth to 5 years of age
The microbiota-metabolite signature of aromatic lactate-producing bifidobacteria and elevated aromatic lactates was inversely associated with development of food allergen-specific IgE until 5 years
The study used a longitudinal birth cohort design tracking microbial colonization and immune outcomes over 5 years
Results
Aromatic lactate-producing bifidobacteria colonization was associated with reduced atopic dermatitis at 2 years of age.
The microbiota-metabolite signature was inversely associated with atopic dermatitis at 2 years
The association was observed in the same 147-child cohort followed from birth
Atopic dermatitis was assessed as a clinical outcome alongside immunological markers
Results
Three early-life practices facilitated transmission of aromatic lactate-producing bifidobacteria: vaginal delivery, exposure to older siblings, and exclusive breastfeeding for the first 2 months.
Vaginal delivery, exposure to older siblings, and exclusive breastfeeding for the first 2 months were all identified as transmission-facilitating factors
These practices were associated with increased levels of aromatic lactates in the infant gut
These findings link common perinatal and feeding practices to the establishment of a protective microbiota-metabolite signature
Results
4-hydroxy-phenyllactate (4-HPL) specifically inhibited IgE production but not IgG production in ex vivo human immune cell cultures.
4-hydroxy-phenyllactate was identified as the mediator of the observed protective effect
The inhibitory effect was selective for IgE and did not extend to IgG production
The finding was demonstrated using ex vivo human immune cell cultures
This selective inhibition suggests a mechanism by which aromatic lactates could reduce allergic sensitization without broadly suppressing humoral immunity
Conclusions
The study defines an early-life microbiota-metabolite-immune axis linking microbial transmission and feeding practices with reduced allergic sensitization.
The axis connects aromatic lactate-producing bifidobacteria colonization, gut aromatic lactate levels, and downstream immune outcomes including IgE and atopic dermatitis
4-hydroxy-phenyllactate was identified as a key mediator within this axis
The axis was characterized in 147 children followed longitudinally from birth to 5 years
The findings integrate microbiological, metabolomic, and immunological data to describe a mechanistic pathway
Background
Early microbial exposures that shape immune development and allergy risk operate through specific microbial taxa producing bioactive metabolites.
Food allergen sensitization, reflected by food allergen-specific IgE, is described as an early indication of impaired immune tolerance
The study identifies aromatic lactate-producing bifidobacteria as a specific functional group relevant to allergy protection
The role of gut microbiota metabolites, particularly aromatic lactates, is highlighted as a mechanistic link between microbial colonization and immune outcomes